Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
IBRN
73
HOLDINGS
29%
ALSO IN SBIO
SBIO
86
HOLDINGS
16%
ALSO IN IBRN
SECTOR DRIFT (IBRN minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
DIANTHUS THERAPEUTICS INC | 5.2% | 3.0% | 3.0% |
|
ACADIA PHARMACEUTICALS INC | 5.0% | 2.5% | 2.5% |
|
EDGEWISE THERAPEUTICS, INC. | 3.5% | 2.4% | 2.4% |
|
DYNE THERAPEUTICS INC | 3.4% | 2.1% | 2.1% |
|
DENALI THERAPEUTICS INC. | 3.7% | 2.0% | 2.0% |
IBRN Overweight Relative to SBIO
|
SCHOLAR ROCK HOLDING CORP. | 4.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.5% |
 |
ARGENX SE ADR | 4.4% |
 |
ALKERMES PLC | 4.2% |
|
BIOGEN IDEC INC | 4.1% |
|
PTC THERAPEUTICS INC | 3.7% |
|
NEUROCRINE BIOSCIENCES INC | 3.5% |
|
AXSOME THERAPEUTICS, INC. | 3.3% |
|
AXOGEN, INC. | 2.6% |
|
SUPERNUS PHARMACEUTICALS INC | 2.5% |
IBRN Underweight Relative to SBIO
|
CRINETICS PHARMACEUTICALS INC | -4.4% |
|
APOGEE THERAPEUTICS, INC. | -4.1% |
|
CG ONCOLOGY, INC. | -3.5% |
|
ORUKA THERAPEUTICS INC | -3.2% |
|
TRAVERE THERAPEUTICS, INC. | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.4% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
VERADERMICS INC | -2.1% |
|
RELAY THERAPEUTICS, INC. | -2.1% |
|
IDEAYA BIOSCIENCES, INC. | -1.7% |